Krishnamurthy Rajesh, Manning Mark C
Human Genome Sciences, Inc., Rockville, MD, USA.
Curr Pharm Biotechnol. 2002 Dec;3(4):361-71. doi: 10.2174/1389201023378229.
Efficient development of stable formulations of protein pharmaceuticals requires an intimate knowledge of the protein and its chemical and physical properties. In particular, understanding the mechanisms by which a protein could degrade is critical for designing and testing formulations. This review describes the major pathways by which proteins can degrade, including denaturation, aggregation, oxidation, and interfacial damage. The methods to detect the degradation are covered, along with generalized strategies to retard or prevent each type of decomposition. Without an appreciation of the current best practices for devising stable formulations, the formulation process will be neither efficient nor optimal.
高效开发蛋白质药物的稳定制剂需要深入了解蛋白质及其化学和物理性质。特别是,了解蛋白质可能降解的机制对于设计和测试制剂至关重要。本文综述了蛋白质降解的主要途径,包括变性、聚集、氧化和界面损伤。文中涵盖了检测降解的方法,以及延缓或防止每种分解类型的通用策略。如果不了解目前设计稳定制剂的最佳实践,制剂过程将既无效率也不理想。